Page 287 - Vitamin D and Cancer

274 R. Okamoto et al.

88. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ (Mar, 2007) Vitamin D in the
treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 103(3–5):793–8
89. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, Stanford J (Jan, 1986)
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis
by human monocytes. Immunology 57(1):159–63
90. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R,
Hanrahan JW, Mader S, White JH (Sep 1, 2004) Cutting edge: 1,25-dihydroxyvitamin
D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173(5):
2909–12
91. Gombart AF, Borregaard N, Koeffler HP (Jul, 2005) Human cathelicidin antimicrobial pep-
tide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in
myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19(9):1067–77
92. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Törmä H, Stahle M (May,
2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol
124(5):1080–2
93. Gombart AF, O’Kelly J, Saito T, Koeffler HP (Mar, 2007) Regulation of the CAMP gene by
1,25(OH)2D3 in various tissues. J Steroid Biochem Mol Biol 103(3–5):552–7
94. Koeffler HP, Bar-Eli M, Territo MC (Mar, 1981) Phorbol ester effect on differentiation of
human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res
41(3):919–26
95. Tonetti M, Cavallero A, Botta GA, Niederman R, Eftimiadi C (Feb, 1991) Intracellular pH
regulates the production of different oxygen metabolites in neutrophils: effects of organic
acids produced by anaerobic bacteria. J Leukoc Biol 49(2):180–8
96. Pan Q, Granger J, O’Connell TD, Somerman MJ, Simpson RU (Oct 15, 1997) Promotion of
HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels
and activity. Biochem Pharmacol 54(8):909–15
97. Berry DM, Meckling-Gill KA (Oct, 1999) Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-
trihomo-lalpha,25(OH)2-vitamin D3, 1,24(OH)2–22-ene-24-cyclopropyl-vitamin D3 and
lalpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via
nongenomic signaling pathways, involving calcium and calpain. Endocrinology
140(10):4779–88
98. Hmama Z, Nandan D, Sly L, Knutson KL, Herrera-Velit P, Reiner NE (Dec 6, 1999)
lalpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vita-
min D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med
190(11):1583–94
99. Marcinkowska E, Wiedlocha A, Radzikowski C (Sep-Oct, 1998) Evidence that phosphati-
dylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells
induced by calcitriol. Anticancer Res 18(5A):3507–14
100. Zhang Y, Zhang J, Studzinski GP (Feb, 2006) AKT pathway is activated by 1, 25-dihy-
droxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in dif-
ferentiating HL60 cells. Cell Cycle 5(4):447–51
101. Marcinkowska E, Wiedłocha A, Radzikowski C (Dec 18, 1997) 1,25-Dihydroxyvitamin D3
induced activation and subsequent nuclear translocation of MAPK is upstream regulated by
PKC in HL-60 cells. Biochem Biophys Res Commun 241(2):419–26
102. Song X, Bishop JE, Okamura WH, Norman AW (Feb, 1998) Stimulation of phosphorylation
of mitogen-activated protein kinase by lalpha,25-dihydroxyvitamin D3 in promyelocytic
NB4 leukemia cells: a structure-function study. Endocrinology 139(2):457–65
103. Ji Y, Kutner A, Verstuyf A, Verlinden L, Studzinski GP (Nov-Dec, 2002) Derivatives of
vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in dif-
ferentiating HL60 cells. Cell Cycle 1(6):410–5
104. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C (Apr 1, 2003) The vitamin D3
analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP
kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia
cells in vitro. Blood 101(7):2454–60